A Prospective "Universal" Observational Database for COVID-19
Completed
Conditions studied: COVID-19
In brief
The Hackensack Meridian Health Universal Observational COVID-19, a descriptive observational database, is a multi-center initiative collecting data throughout the Hackensack Meridian Health Network (HMH). HMH utilizes the EPIC system at most of the facilities, which will serve as the primary data source. The database will be designed within the REDCap system. A de-identified dataset will be sent to COTA for primary statistical analysis as requested by the research teams.
Key facts
- Study ID
- NCT04347993
- Run by
- Hackensack Meridian Health
- People needed
- 4588
- Starts
- 2020-03-27
- Expected to finish
- 2023-06-12
- Last updated by the study team
- 2024-09-03
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Confirmed or suspected COVID-19
- Data available via the EPIC system
- NO age restriction
- NO pregnancy restrictions
You may not qualify if…
- Patients on a clinical trial in which the treatment is blinded may be included in the database, however the study medication or treatment will be noted as "experimental" and not reported individually. NO efforts to "break" randomization or blinding will be permitted
- Patients may refuse to be tracked in the database and/or participate in this observational study. Given the lack of active "study" procedures in this observational database, formal informed consent is not required
Where it is running
- Hackensack Meridian Health - John Theurer Cancer Center — Hackensack, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.